by DAVID.KIEWLICH | Aug 21, 2026 | Biotech
Dr. David Kiewlich spent 18 months looking for lab space before he could conduct his first experiment as a founder. That’s 18 months of burn rate and no data. He had to go back to investors and ask for more money to get proof of concept data. His company needed...
by DAVID.KIEWLICH | Aug 20, 2026 | Biotech
It’s 2:47am. Your cells have reached the exact confluence you need for your assay. Your PCR is done running. Your western blot is ready to image. You have the data you’ve been trying to get for 3 months, and you need to review it. The problem? You’re not allowed...
by DAVID.KIEWLICH | Aug 13, 2026 | Biotech
Biotech is the cutting edge of human advancement. Gene therapies are curing rare diseases. Cell-based immunotherapies are redefining oncology. Carbon-capturing biology and engineered materials are shaping climate change. The research has never been more exciting. Yet...
by DAVID.KIEWLICH | Aug 7, 2026 | Biotech
Nearly 90% of biotech startups fail. This number is so ingrained in biotech that almost everyone treats it as a given. But maybe we are looking at things backwards. What if failing wasn’t the opposite of success, but what you needed to get there? At BADASS Labs, our...
by DAVID.KIEWLICH | Aug 6, 2026 | Incubator
Let’s talk about a number that haunts every biotech startup founder: 10%. Many incubators and accelerators take 10% equity for providing lab space, mentorship and connections. Ten percent of your future funding, your future milestones, your future exit, gone before...
